المؤلفون: Andrew Zelenetz, Js, Abramson, Rh, Advani, Cb, Andreadis, Jc, Byrd, Ms, Czuczman, Fayad L, Forero A, Mj, Glenn, Jp, Gockerman, Li, Gordon, Nl, Harris, Rt, Hoppe, Sm, Horwitz, Ms, Kaminski, Yh, Kim, As, Lacasce, Ti, Mughal, Nademanee A, Porcu P, Press O, Prosnitz L, Reddy N, Smith MR, Sokol L, Swinnen L, Jm, Vose, Wg, Wierda, Yahalom J, Yunus F

المصدر: Europe PubMed Central

مصطلحات موضوعية: Lymphoma, Non-Hodgkin, Humans, Neoplasm Staging

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e8e00df83cbdacf02ae0bdc6935dd686
https://pubmed.ncbi.nlm.nih.gov/20202462

المؤلفون: Mehta A; UAB, Birmingham, Alabama, United States., Popplewell L; City of Hope, Duarte, California, United States., Collins GP; Oxford University Hospitals, Oxford, United Kingdom., Smith SM; University of Chicago, Chicago, Illinois, United States., Flinn IW; Tennessee Oncology and OneOncology, Nashville, Tennessee, United States., Bartlett NL; Washington University School of Medicine, St. Louis, Missouri, United States., Ghosh N; Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, United States., Hacohen-Kleiman G; Gilead Sciences, Inc., Foster City, California, United States., Huo Y; Gilead Sciences, Inc., Foster City, California, United States., Su-Feher L; Gilead Sciences, Inc., Foster City, California, United States., Renard C; Obsidian therapeutics, redwood city, California, United States., Advani RH; Stanford University, Stanford, California, United States., Roschewski M; National Cancer Institute, NIH, Bethesda, Maryland, United States.

المصدر: Blood advances [Blood Adv] 2024 Aug 30. Date of Electronic Publication: 2024 Aug 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

المؤلفون: Schroers-Martin JG; Department of Medicine, Division of Oncology, Stanford University, Stanford, CA., Advani RH; Department of Medicine, Division of Oncology, Stanford University, Stanford, CA. Electronic address: radvani@stanford.edu.

المصدر: Seminars in hematology [Semin Hematol] 2024 Jun 14. Date of Electronic Publication: 2024 Jun 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0404514 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8686 (Electronic) Linking ISSN: 00371963 NLM ISO Abbreviation: Semin Hematol Subsets: MEDLINE

المؤلفون: Spinner MA; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, USA., Advani RH; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA, USA.

المصدر: Expert opinion on emerging drugs [Expert Opin Emerg Drugs] 2024 May 06, pp. 1-13. Date of Electronic Publication: 2024 May 06.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101135662 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7623 (Electronic) Linking ISSN: 14728214 NLM ISO Abbreviation: Expert Opin Emerg Drugs Subsets: MEDLINE

المؤلفون: Brouwer-Visser J; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA jurriaan.brouwer@regeneron.com., Fiaschi N; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Deering RP; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Cygan KJ; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Scott D; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Jeong S; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Boucher L; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Gupta NT; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Gupta S; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Adler C; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Topp MS; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany., Bannerji R; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Duell J; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany., Advani RH; Department of Medicine, Stanford University, Stanford, California, USA., Flink DM; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Chaudhry A; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Thurston G; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Ambati SR; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA., Jankovic V; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Mar 21; Vol. 12 (3). Date of Electronic Publication: 2024 Mar 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/therapeutic use , Lymphoma, Large B-Cell, Diffuse*/drug therapy , Lymphoma, Large B-Cell, Diffuse*/genetics , Antibodies, Bispecific*/pharmacology , Antibodies, Bispecific*/therapeutic use, Humans ; Treatment Outcome ; Antigens, CD20

المؤلفون: Vose JM; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Nebraska Medicine Fred and Pamela Buffett Cancer Center, 505 S 45Th St, Omaha, NE, 68105, USA., Fu K; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Wang L; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, China., Mansoor A; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Canada., Stewart D; Departments of Oncology and Medicine, University of Calgary, Calgary, Canada., Cheng H; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.; Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China., Smith L; Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE, USA., Yuan J; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Qureishi HN; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Link BK; Department of Internal Medicine, University of Iowa Hospitals & Clinics, Iowa City, Iowa, USA., Cessna MH; Department of Pathology, Intermountain Medical Center, Murray, UT, USA., Barr PM; Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA., Kahl BS; Department of Medicine, Oncology Division, Washington University School of Medicine in St. Louis, St. Louis, MO, USA., Mckinney MS; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC, USA., Khan N; Department of Hematology/Oncology, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Advani RH; Division of Oncology, Stanford Cancer Institute, Stanford, CA, USA., Martin P; Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY, USA., Goy AH; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ, USA., Phillips TJ; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI, USA., Mehta A; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Kamdar M; Division of Hematology, University of Colorado, Denver, CO, USA., Crump M; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada., Pro B; Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, USA., Flowers CR; Division of Cancer Medicine, Department of Lymphoma-Myeloma, MD Anderson Cancer Center, Houston, TX, USA., Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Smith SM; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA., Stephens DM; Huntsman Cancer Institute at University of Utah, Salt Lake City, UT, USA., Bachanova V; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Jin Z; Department of Oncology, Mayo Clinic, Rochester, MN, USA., Wu S; Department of Pathology, Affiliated Yantai Yuhuangding Hospital, Qingdao University, No.20 Yuhuangding East Road, Yantai, 264000, China., Hernandez-Ilizaliturri F; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Torka P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Anampa-Guzmán A; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Kashef F; Department of Pathology, University at Buffalo, Buffalo, NY, USA., Li X; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Sharma S; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Greiner TC; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Armitage JO; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Nebraska Medicine Fred and Pamela Buffett Cancer Center, 505 S 45Th St, Omaha, NE, 68105, USA., Lunning M; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Nebraska Medicine Fred and Pamela Buffett Cancer Center, 505 S 45Th St, Omaha, NE, 68105, USA., Weisenburger DD; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Bociek RG; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Nebraska Medicine Fred and Pamela Buffett Cancer Center, 505 S 45Th St, Omaha, NE, 68105, USA., Iqbal J; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Yu G; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA. guohuayu@qdu.edu.cn.; Department of Pathology, Affiliated Yantai Yuhuangding Hospital, Qingdao University, No.20 Yuhuangding East Road, Yantai, 264000, China. guohuayu@qdu.edu.cn., Bi C; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Nebraska Medicine Fred and Pamela Buffett Cancer Center, 505 S 45Th St, Omaha, NE, 68105, USA. andy.bi@unmc.edu.

مؤلفون مشاركون: North American Mantle Cell Lymphoma Consortium

المصدر: Journal of hematology & oncology [J Hematol Oncol] 2023 Dec 16; Vol. 16 (1), pp. 122. Date of Electronic Publication: 2023 Dec 16.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Mantle-Cell*/drug therapy , Lymphoma, Mantle-Cell*/pathology, Adult ; Humans ; Prognosis ; Retrospective Studies ; Risk Factors ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; North America

المؤلفون: Desai SH; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN.; Division of Hematology, Mayo Clinic, Rochester, MN., Spinner MA; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA., Evens AM; Department of Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Sykorova A; University Hospital and Faculty of Medicine, Hradec Kralove, Hradec Kralove, Czech Republic., Bachanova V; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN., Goyal G; Division of Hematology & Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL., Kahl B; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO., Dorritie K; Division of Hematology & Oncology, Department of Medicine, UPMC Hillman Cancer Center, Pittsburgh, PA., Azzi J; Icahn School of Medicine Mount Sinai, New York, NY., Kenkre VP; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin, Madison, WI., Chang C; Division of Oncology, Department of Medicine, Stanford University Medical Center, Stanford, CA., Michalka J; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Ansell SM; Division of Hematology, Mayo Clinic, Rochester, MN., Fusco B; Department of Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Sumransub N; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN., Hatic H; Division of Hematology & Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL., Saba R; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO., Ibrahim U; Icahn School of Medicine Mount Sinai, New York, NY., Harris EI; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin, Madison, WI., Shah H; Division of Hematology, Department of Medicine, Hunstman Cancer Institute, The University of Utah, Salt Lake City, UT., Wagner-Johnston N; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD., Arai S; Division of Oncology, Department of Medicine, Stanford University Medical Center, Stanford, CA., Nowakowski GS; Division of Hematology, Mayo Clinic, Rochester, MN., Mocikova H; Department of Clinical Hematology, Charles University in Prague, Prague, Czech Republic., Jagadeesh D; Cleveland Clinic Foundation, Cleveland, OH., Blum KA; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA., Diefenbach C; Perlmutter Cancer Center, NYU Grossman Medical School, New York, NY., Iyengar S; Division of Hematology, Department of Medicine, Hunstman Cancer Institute, The University of Utah, Salt Lake City, UT., Rappazzo KC; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD., Baidoun F; Cleveland Clinic Foundation, Cleveland, OH., Choi Y; Perlmutter Cancer Center, NYU Grossman Medical School, New York, NY., Prochazka V; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Czech Republic., Advani RH; Division of Oncology, Department of Medicine, Stanford University Medical Center, Stanford, CA., Micallef I; Division of Hematology, Mayo Clinic, Rochester, MN.

المصدر: Blood advances [Blood Adv] 2023 Dec 12; Vol. 7 (23), pp. 7295-7303.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Hodgkin Disease*/therapy , Immunoconjugates*, Adult ; Female ; Humans ; Male ; Brentuximab Vedotin ; Retrospective Studies ; Stem Cell Transplantation ; Middle Aged

المؤلفون: Zelenetz AD; Memorial Sloan Kettering Cancer Center., Gordon LI; Robert H. Lurie Comprehensive Cancer Center of Northwestern University., Abramson JS; Massachusetts General Hospital Cancer Center., Advani RH; Stanford Cancer Institute., Andreadis B; UCSF Helen Diller Family Comprehensive Cancer Center., Bartlett NL; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine., Budde LE; City of Hope National Medical Center., Caimi PF; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute., Chang JE; University of Wisconsin Carbone Cancer Center., Christian B; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute., DeVos S; UCLA Jonsson Comprehensive Cancer Center., Dholaria B; Vanderbilt-Ingram Cancer Center., Fayad LE; The University of Texas MD Anderson Cancer Center., Habermann TM; Mayo Clinic Comprehensive Cancer Center., Hamid MS; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center., Hernandez-Ilizaliturri F; Roswell Park Comprehensive Cancer Center., Hu B; Huntsman Cancer Institute at the University of Utah., Kaminski MS; University of Michigan Rogel Cancer Center., Karimi Y; University of Michigan Rogel Cancer Center., Kelsey CR; Duke Cancer Institute., King R; Mayo Clinic Comprehensive Cancer Center., Krivacic S; Consultant., LaCasce AS; Dana-Farber/Brigham and Women's Cancer Center., Lim M; Memorial Sloan Kettering Cancer Center., Messmer M; Fox Chase Cancer Center., Narkhede M; O'Neal Comprehensive Cancer Center at UAB., Rabinovitch R; University of Colorado Cancer Center., Ramakrishnan P; UT Southwestern Simmons Comprehensive Cancer Center., Reid E; UC San Diego Moores Cancer Center., Roberts KB; Yale Cancer Center/Smilow Cancer Hospital., Saeed H; Moffitt Cancer Center., Smith SD; Fred Hutchinson Cancer Center., Svoboda J; Abramson Cancer Center at the University of Pennsylvania., Swinnen LJ; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins., Tuscano J; UC Davis Comprehensive Cancer Center., Vose JM; Fred & Pamela Buffett Cancer Center., Dwyer MA; National Comprehensive Cancer Network., Sundar H; National Comprehensive Cancer Network.

المصدر: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2023 Nov; Vol. 21 (11), pp. 1118-1131.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Large B-Cell, Diffuse*/drug therapy , Lymphoma, Follicular*/drug therapy , Lymphoma, Mantle-Cell*/drug therapy , Lymphoma, Mantle-Cell*/pathology, Humans ; Adult ; Immunotherapy, Adoptive ; T-Lymphocytes

المؤلفون: Hapgood G; Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia., Civallero M; CHIMOMO Department, University of Modena and Reggio Emilia, Modena, Italy., Stepanishyna Y; Kiev National Cancer Institute, Kiev, Ukraine., Vose J; University of Nebraska Medical Center, Omaha, NE., Cabrera ME; Hematology Section, Hospital del Salvador, University of Chile, Santiago de Chile, Chile., Advani RH; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Pileri SA; Division of Diagnostic Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy., Manni M; CHIMOMO Department, University of Modena and Reggio Emilia, Modena, Italy., Horwitz SM; Department Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Foss FM; Yale University School of Medicine, New Haven, CT., Hitz F; The Swiss Group for Clinical Cancer Research, Department of Oncology/Haematology, Cantonal Hospital, St. Gallen, Switzerland., Radford J; Medical Oncology, University of Manchester, Manchester, England., Dlouhy I; Clinic Barcelona, Hospital Universitari, Barcelona, Spain., Chiattone C; Santa Casa Medical School of Sao Paulo and Samaritan Hospital, Sao Paulo, Brazil., Kim WS; Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea., Skrypets T; Hematology, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy., Nagler A; Hematology Division BMT and Cord Blood Bank Chaim Sheba Medical Center Tel-Hashomer, Ramat-Gan, Israel., Trotman J; Department of Haematology, Concord Hospital, University of Sydney, Sydney, Australia., Luminari S; CHIMOMO Department, University of Modena and Reggio Emilia, Modena, Italy.; Hematology, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy., Federico M; CHIMOMO Department, University of Modena and Reggio Emilia, Modena, Italy.

المصدر: Blood advances [Blood Adv] 2023 Sep 12; Vol. 7 (17), pp. 5047-5054.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, T-Cell, Peripheral*/diagnosis , Lymphoma, T-Cell, Peripheral*/therapy, Humans ; Infant ; Child, Preschool ; Child ; Middle Aged ; Prognosis ; Australia/epidemiology ; T-Lymphocytes/pathology ; Anthracyclines

المؤلفون: Stuver R; Memorial Sloan Kettering Cancer Center, Manhattan, New York, USA., Horwitz SM; Memorial Sloan Kettering Cancer Center, Manhattan, New York, USA., Advani RH; Stanford University, Stanford, California, USA., Vose JM; University of Nebraska Medical Center, Omaha, Nebraska, USA., Lee HJ; MD Anderson Cancer Center, Houston, Texas, USA., Mehta-Shah N; Washington University in St. Louis, St. Louis, Missouri, USA., Zain JM; City of Hope, Duarte, California, USA., Haverkos B; University of Colorado, Boulder, Colorado, USA., Lechowicz MJ; Emory University, Atlanta, Georgia, USA., Moskowitz AJ; Memorial Sloan Kettering Cancer Center, Manhattan, New York, USA., Pham LQ; Oakland University William Beaumont School of Medicine, Rochester, Michigan, USA., Leyden E; University of Nebraska Medical Center, Omaha, Nebraska, USA., Ansell SM; Mayo Clinic, Rochester, Minnesota, USA., Lunning MA; University of Nebraska Medical Center, Omaha, Nebraska, USA.

المصدر: British journal of haematology [Br J Haematol] 2023 Aug; Vol. 202 (3), pp. 525-529. Date of Electronic Publication: 2023 May 22.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, T-Cell, Peripheral*/drug therapy, Humans ; Lenalidomide ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Remission Induction